Multifidus Cervicis and Inter-Semispinal Plane Blocks in Analgesia After Cervical Spine Surgery
Launched by ZAGAZIG UNIVERSITY · Oct 8, 2023
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring two different methods of pain relief for patients undergoing cervical spine surgery. The goal is to determine which method provides better pain control after surgery, helping patients recover more effectively and return to their daily activities sooner. The techniques being compared are called multifidus cervicis plane block and inter-semispinal plane block. Both methods aim to reduce the need for strong pain medications, which can have side effects and complicate recovery.
To participate in this study, patients should be between 21 and 60 years old, have a body mass index (BMI) of 30 or less, and be scheduled for elective cervical spine surgery. However, those with certain health issues, allergies to the medications used, or a history of chronic pain may not be eligible. Participants can expect to receive one of the pain control techniques before their surgery and will be monitored for pain levels and recovery progress. This research is important because effective pain management can greatly improve the surgery experience and overall outcomes for patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient acceptance.
- • Age 21-60 years old.
- • BMI ≤ 30 kg/m2
- • ASA I - II.
- • Elective posterior cervical spine surgery under general anesthesia.
- Exclusion Criteria:
- • History of allergy to the LA agents used in this study
- • Skin lesion at the needle insertion site,
- • Those with bleeding disorders, sepsis, liver disease, and psychiatric disorders
- • History of chronic pain and taking analgesics
- • History of cognitive dysfunction or mental illness
About Zagazig University
Zagazig University, a prominent educational and research institution located in Egypt, plays a pivotal role in advancing medical knowledge and promoting health innovations through its clinical trials. With a commitment to excellence in research, the university leverages its diverse expertise and state-of-the-art facilities to conduct rigorous clinical studies that aim to improve patient care and outcomes. By fostering collaboration among multidisciplinary teams, Zagazig University contributes significantly to the global medical community, ensuring that its clinical trials adhere to the highest ethical standards and regulatory requirements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zagazig, Alsharqia, Egypt
Patients applied
Trial Officials
Shereen E Abd Ellatif, MD
Principal Investigator
Faculty of medicine, zagazig university
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported